{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:33:11Z","timestamp":1789878791860,"version":"4.0.1"},"reference-count":80,"publisher":"Oxford University Press (OUP)","issue":"R2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10,1]]},"DOI":"10.1093\/hmg\/ddx215","type":"journal-article","created":{"date-parts":[[2017,6,6]],"date-time":"2017-06-06T08:21:17Z","timestamp":1496737277000},"page":"R151-R159","source":"Crossref","is-referenced-by-count":75,"title":["Spinal muscular atrophy: antisense oligonucleotide therapy opens the door to an integrated therapeutic landscape"],"prefix":"10.1093","volume":"26","author":[{"given":"Matthew J.A.","family":"Wood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Bowerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,6,13]]},"reference":[{"key":"key\n\t\t\t\t20171011225635_ddx215-B1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/jmg.15.6.409","article-title":"Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy","volume":"15","year":"1978","journal-title":"J. Med. Genet"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/nbdi.1996.0010","article-title":"The neurobiology of childhood spinal muscular atrophy","volume":"3","year":"1996","journal-title":"Neurobiol. Dis"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","year":"1995","journal-title":"Cell"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B4","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/hmg\/ddm367","article-title":"Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy","volume":"17","year":"2008","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B5","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1093\/hmg\/ddq329","article-title":"Cardiac defects contribute to the pathology of spinal muscular atrophy models","volume":"19","year":"2010","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B6","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1093\/hmg\/ddq330","article-title":"Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice","volume":"19","year":"2010","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B7","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/jmg.2008.057950","article-title":"Congenital heart disease is a feature of severe infantile spinal muscular atrophy","volume":"45","year":"2008","journal-title":"J. Med. Genet"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B8","doi-asserted-by":"crossref","first-page":"34635.","DOI":"10.1038\/srep34635","article-title":"Survival motor neuron (SMN) protein is required for normal mouse liver development","volume":"6","year":"2016","journal-title":"Sci. Rep"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B9","first-page":"801","article-title":"Immune dysregulation may contribute to disease pathogenesis in spinal muscular atrophy mice","volume":"26","year":"2017","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/joa.12546","article-title":"Survival of motor neurone protein is required for normal postnatal development of the spleen","volume":"230","year":"2017","journal-title":"J. Anat"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B11","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1093\/hmg\/ddv127","article-title":"SMN deficiency disrupts gastrointestinal and enteric nervous system function in mice","volume":"24","year":"2015","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B12","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/ana.23582","article-title":"Glucose metabolism and pancreatic defects in spinal muscular atrophy","volume":"72","year":"2012","journal-title":"Ann. Neurol"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B13","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1093\/hmg\/ddq340","article-title":"SMN deficiency disrupts brain development in a mouse model of severe spinal muscular atrophy","volume":"19","year":"2010","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B14","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.nmd.2011.10.021","article-title":"Density, calibre and ramification of muscle capillaries are altered in a mouse model of severe spinal muscular atrophy","volume":"22","year":"2012","journal-title":"Neuromuscul. Disord. NMD"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B15","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1093\/hmg\/ddt612","article-title":"SMN-dependent intrinsic defects in Schwann cells in mouse models of spinal muscular atrophy","volume":"23","year":"2014","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B16","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/ejhg.2012.222","article-title":"Severe SMA mice show organ impairment that cannot be rescued by therapy with the HDACi JNJ-26481585","volume":"21","year":"2013","journal-title":"Eur. J. Hum. Genet. EJHG"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/0883073807299954","article-title":"Neonatal spinal muscular atrophy type 1 with bone fractures and heart defect","volume":"22","year":"2007","journal-title":"J. Child Neurol"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B18","doi-asserted-by":"crossref","first-page":"9920","DOI":"10.1073\/pnas.94.18.9920","article-title":"Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos","volume":"94","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s004390100473","article-title":"SMN gene duplication and the emergence of the SMN2 gene occurred in distinct hominids: SMN2 is unique to Homo sapiens","volume":"108","year":"2001","journal-title":"Hum. Genet"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B20","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/hmg\/8.7.1177","article-title":"A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2","volume":"8","year":"1999","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B21","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0167-4781(99)00060-3","article-title":"Promoter analysis of the human centromeric and telomeric survival motor neuron genes (SMNC and SMNT)","volume":"1445","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B22","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/sj.ejhg.5201217","article-title":"Survival motor neuron SMN1 and SMN2 gene promoters: identical sequences and differential expression in neurons and non-neuronal cells","volume":"12","year":"2004","journal-title":"Eur. J. Hum. Genet"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B23","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","article-title":"A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy","volume":"96","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ng854","article-title":"Disruption of an SF2\/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1","volume":"30","year":"2002","journal-title":"Nat. Genet"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B25","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/ng1207","article-title":"A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy","volume":"34","year":"2003","journal-title":"Nat. Genet"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/ng0797-265","article-title":"Correlation between severity and SMN protein level in spinal muscular atrophy","volume":"16","year":"1997","journal-title":"Nat. Genet"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1090-3798(99)80015-4","article-title":"Prenatal onset spinal muscular atrophy","volume":"3","year":"1999","journal-title":"Eur. J. Paediatr. Neurol"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1090-3798(99)80012-9","article-title":"Very severe spinal muscular atrophy (SMA type 0): an expanding clinical phenotype","volume":"3","year":"1999","journal-title":"Eur. J. Paediatr. Neurol"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B29","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/brain\/101.4.591","article-title":"A clinical and genetic study of spinal muscular atrophy of adult onset: the autosomal recessive form as a discrete disease entity","volume":"101","year":"1978","journal-title":"Brain J. Neurol"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B30","first-page":"919","article-title":"Classification of spinal muscular atrophies","volume":"1","year":"1980","journal-title":"Lancet Lond. Engl"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B31","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0960-8966(06)80015-5","article-title":"International SMA consortium meeting. (26-28 June 1992, Bonn, Germany)","volume":"2","year":"1992","journal-title":"Neuromuscul. Disord. NMD"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1590\/S1415-47572013000300001","article-title":"Histone deacetylase inhibitors as potential treatment for spinal muscular atrophy","volume":"36","year":"2013","journal-title":"Genet. Mol. Biol"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B33","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nrneurol.2015.77","article-title":"Spinal muscular atrophy\u2013recent therapeutic advances for an old challenge","volume":"11","year":"2015","journal-title":"Nat. Rev. Neurol"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B34","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0000000000002445","article-title":"Results from a phase 1 study of nusinersen (ISIS-SMN(Rx)) in children with spinal muscular atrophy","volume":"86","year":"2016","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B35","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1016\/S0140-6736(16)31408-8","article-title":"Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study","volume":"388","year":"2016","journal-title":"Lancet Lond. Engl"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B36","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.4155\/fmc.15.101","article-title":"Mechanistic principles of antisense targets for the treatment of spinal muscular atrophy","volume":"7","year":"2015","journal-title":"Future Med. Chem"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B37","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1089\/hum.2012.225","article-title":"Antisense oligonucleotides for the treatment of spinal muscular atrophy","volume":"24","year":"2013","journal-title":"Hum. Gene Ther"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.mcn.2013.04.005","article-title":"Splicing therapy for neuromuscular disease","volume":"56","year":"2013","journal-title":"Mol. Cell. Neurosci"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B39","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ajhg.2008.01.014","article-title":"Antisense masking of an hnRNP A1\/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice","volume":"82","year":"2008","journal-title":"Am. J. Hum. Genet"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B40","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1128\/MCB.26.4.1333-1346.2006","article-title":"Splicing of a critical exon of human survival motor neuron is regulated by a unique silencer element located in the last intron","volume":"26","year":"2006","journal-title":"Mol. Cell. Biol"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B41","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/hmg\/ddr600","article-title":"A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse","volume":"21","year":"2012","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B42","first-page":"562","article-title":"Pharmacokinetics of phosphorothioate antisense oligodeoxynucleotides","volume":"2","year":"2001","journal-title":"Curr. Opin. Investig. Drugs Lond. Engl. 2000"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B43","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.nmd.2011.09.007","article-title":"A critical smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology","volume":"22","year":"2012","journal-title":"Neuromuscul. Disord. NMD"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B44","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1212\/WNL.0000000000000741","article-title":"Observational study of spinal muscular atrophy type I and implications for clinical trials","volume":"83","year":"2014","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B45","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1034\/j.1399-3011.2000.00723.x","article-title":"Polyarginine enters cells more efficiently than other polycationic homopolymers","volume":"56","year":"2000","journal-title":"J. Pept. Res. Off. J. Am. Pept. Soc"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B46","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1517\/17425247.2016.1125879","article-title":"Recent in vivo advances in cell-penetrating peptide-assisted drug delivery","volume":"13","year":"2016","journal-title":"Expert Opin. Drug Deliv"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B47","doi-asserted-by":"crossref","first-page":"10962","DOI":"10.1073\/pnas.1605731113","article-title":"Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy","volume":"113","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B48","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1073\/pnas.1613203114","article-title":"Effects of systemic multiexon skipping with peptide-conjugated morpholinos in the heart of a dog model of Duchenne muscular dystrophy","volume":"114","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B49","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrd4363","article-title":"Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies","volume":"13","year":"2014","journal-title":"Nat. Rev. Drug Discov"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B50","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuron.2016.11.033","article-title":"The antisense transcript SMN-AS1 regulates SMN expression and is a novel therapeutic target for spinal muscular atrophy","volume":"93","year":"2017","journal-title":"Neuron"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B51","doi-asserted-by":"crossref","first-page":"E1509","DOI":"10.1073\/pnas.1616521114","article-title":"Gene activation of SMN by selective disruption of lncRNA-mediated recruitment of PRC2 for the treatment of spinal muscular atrophy","volume":"114","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B52","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1124\/jpet.114.222224","article-title":"The small-molecule fast skeletal troponin activator, CK-2127107, improves exercise tolerance in a rat model of heart failure","volume":"353","year":"2015","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B53","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.molmed.2012.11.002","article-title":"Spinal muscular atrophy: going beyond the motor neuron","volume":"19","year":"2013","journal-title":"Trends Mol. Med"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B54","doi-asserted-by":"crossref","first-page":"68.","DOI":"10.1186\/s12883-017-0853-y","article-title":"A qualitative study of perceptions of meaningful change in spinal muscular atrophy","volume":"17","year":"2017","journal-title":"BMC Neurol"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B55","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1161\/ATVBAHA.111.241919","article-title":"Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease","volume":"32","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B56","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/CIRCULATIONAHA.107.702795","article-title":"Metabolic mechanisms in heart failure","volume":"116","year":"2007","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B57","doi-asserted-by":"crossref","first-page":"E415","DOI":"10.1152\/ajpendo.90887.2008","article-title":"Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetes","volume":"296","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B58","doi-asserted-by":"crossref","first-page":"e216.","DOI":"10.1038\/emm.2016.4","article-title":"Emerging role of the brain in the homeostatic regulation of energy and glucose metabolism","volume":"48","year":"2016","journal-title":"Exp. Mol. Med"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B59","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jamda.2016.04.019","article-title":"Skeletal muscle regulates metabolism via interorgan crosstalk: roles in health and disease","volume":"17","year":"2016","journal-title":"J. Am. Med. Dir. Assoc"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B60","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(95)91439-0","article-title":"Hypoglycaemia in spinal muscular atrophy","volume":"346","year":"1995","journal-title":"Lancet Lond. Engl"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B61","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jpeds.2015.09.023","article-title":"Responses to fasting and glucose loading in a cohort of well children with spinal muscular atrophy type II","volume":"167","year":"2015","journal-title":"J. Pediatr"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B62","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.bbrc.2009.11.148","article-title":"Effect of diet on the survival and phenotype of a mouse model for spinal muscular atrophy","volume":"391","year":"2010","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B63","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1093\/hmg\/ddu052","article-title":"Defects in pancreatic development and glucose metabolism in SMN-depleted mice independent of canonical spinal muscular atrophy neuromuscular pathology","volume":"23","year":"2014","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B64","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1172\/JCI29562","article-title":"Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy","volume":"117","year":"2007","journal-title":"J. Clin. Invest"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B65","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/mt.2014.209","article-title":"PTEN depletion decreases disease severity and modestly prolongs survival in a mouse model of spinal muscular atrophy","volume":"23","year":"2015","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B66","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1093\/hmg\/ddr067","article-title":"Increased IGF-1 in muscle modulates the phenotype of severe SMA mice","volume":"20","year":"2011","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B67","doi-asserted-by":"crossref","first-page":"7615","DOI":"10.1523\/JNEUROSCI.1245-05.2005","article-title":"Regular exercise prolongs survival in a type 2 spinal muscular atrophy model mouse","volume":"25","year":"2005","journal-title":"J. Neurosci. Off. J. Soc. Neurosci"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B68","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.phrs.2016.05.023","article-title":"Loganin possesses neuroprotective properties, restores SMN protein and activates protein synthesis positive regulator Akt\/mTOR in experimental models of spinal muscular atrophy","volume":"111","year":"2016","journal-title":"Pharmacol. Res"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B69","doi-asserted-by":"crossref","first-page":"3.","DOI":"10.1186\/s12967-015-0762-z","article-title":"Insulin-like growth factor-1 deficiency and metabolic syndrome","volume":"14","year":"2016","journal-title":"J. Transl. Med"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B70","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bcp.2008.04.004","article-title":"Trichostatin A improves insulin stimulated glucose utilization and insulin signaling transduction through the repression of HDAC2","volume":"76","year":"2008","journal-title":"Biochem. Pharmacol"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B71","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1073\/pnas.1213773111","article-title":"Regulation of PTEN inhibition by the pleckstrin homology domain of P-REX2 during insulin signaling and glucose homeostasis","volume":"111","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B72","first-page":"2868652.","article-title":"Influence of acute and chronic exercise on glucose uptake","volume":"2016","year":"2016","journal-title":"J. Diabetes Res"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B73","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.lfs.2014.12.028","article-title":"Loganin attenuates diabetic nephropathy in C57BL\/6J mice with diabetes induced by streptozotocin and fed with diets containing high level of advanced glycation end products","volume":"123","year":"2015","journal-title":"Life Sci"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B74","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ejpn.2012.01.004","article-title":"Abnormal fatty acid metabolism in spinal muscular atrophy may predispose to perioperative risks","volume":"16","year":"2012","journal-title":"Eur. J. Paediatr. Neurol"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B75","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/1531-8249(199903)45:3<337::AID-ANA9>3.0.CO;2-U","article-title":"Abnormal fatty acid metabolism in childhood spinal muscular atrophy","volume":"45","year":"1999","journal-title":"Ann. Neurol"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B76","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0887-8994(94)00100-G","article-title":"Fatty acid oxidation abnormalities in childhood-onset spinal muscular atrophy: primary or secondary defect(s)?","volume":"12","year":"1995","journal-title":"Pediatr. Neurol"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B77","doi-asserted-by":"crossref","first-page":"e0173144.","DOI":"10.1371\/journal.pone.0173144","article-title":"Hyperleptinemia in children with autosomal recessive spinal muscular atrophy type I-III","volume":"12","year":"2017","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B78","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.nmd.2009.03.009","article-title":"Increased fat mass and high incidence of overweight despite low body mass index in patients with spinal muscular atrophy","volume":"19","year":"2009","journal-title":"Neuromuscul. Disord. NMD"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B79","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/ana.21449","article-title":"Sustained improvement of spinal muscular atrophy mice treated with trichostatin A plus nutrition","volume":"64","year":"2008","journal-title":"Ann. Neurol"},{"key":"key\n\t\t\t\t20171011225635_ddx215-B80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2014.03.005","article-title":"The effect of diet on the protective action of D156844 observed in spinal muscular atrophy mice","volume":"256","year":"2014","journal-title":"Exp. Neurol"}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/26\/R2\/R151\/20425066\/ddx215.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T17:08:20Z","timestamp":1569431300000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/hmg\/article\/26\/R2\/R151\/3867126\/Spinal-muscular-atrophy-antisense-oligonucleotide"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,13]]},"references-count":80,"journal-issue":{"issue":"R2","published-online":{"date-parts":[[2017,6,13]]},"published-print":{"date-parts":[[2017,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddx215","relation":{},"ISSN":["0964-6906","1460-2083"],"issn-type":[{"value":"0964-6906","type":"print"},{"value":"1460-2083","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,10,1]]},"published":{"date-parts":[[2017,6,13]]}}}